Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2022-05-10 00:00:00 ET · period of report 2021-11-01 · accession 0001213900-22-025288 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-10 | 2021-11-01 | ORMP | Mayer Arie | Dir | S - Sale | $25.60 | -3,000 | 0 | -100% | -$76.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | S | D | 3,000 | $25.60 | 0 | D | — | — |